Table 3.
Turkish N = 55 n (%) |
Moroccan N = 101 n (%) |
P | Total Turkish/Moroccan N = 156 n (%) |
Comparative group N = 321 n (%) |
P | |
---|---|---|---|---|---|---|
Total eligible | 18 (32.7) | 37 (36.6) | 0.63 | 55 (35.3) | 66 (20.6) | 0.001 |
Personal cancer history | ||||||
Age at diagnose | ||||||
<40 years | 11 (20.0) | 29 (28.7) | 0.23 | 40 (25.6) | 16 (5.0) | 0.0001 |
Contralateral or ipsilateral BC < 50 years | 2 (3.6) | 3 (3.0) | – | 5 (3.2) | 7 (2.2) | 0.503 |
OVCA | 0 | 0 | – | 0 (0) | 2 (0.6) | – |
Family cancer history | ||||||
OVCA in family | 0 | 1 (1) | – | 1 (0.6) | 12 (3.7) | – |
BC in family | 8 (14.5) | 8 (7.9) | 0.19 | 16 (10.3) | 39 (12.1) | 0.54 |
Male BC in family | 1 (1.8) | 2 (2.0) | – | 3 (1.9) | 1 (0.3) | – |
BC breast cancer, OVCA ovarian cancer
Contralateral or ipsilateral BC < 50 years: BC patients of all ages with a contralateral and/or ipsilateral BC diagnosed before the age of 50
OVCA in family: all BC patients who have a family member with OVCA
For a few variables, Chi square statistics could not be calculated because > 20 % of the cells had an expected count of 0.5
BC in family: BC patients of all ages at diagnosis who have two or more first and/or second degree family members with BC (same family branch) and/or one first degree family member with BC diagnosed before the age of 50 and/or patients who were younger than 50 years at diagnosis who have at least one family member with BC
Male BC: 1 or more male first degree family members with BC
* Patients can fulfil one or more criteria